BachirSakrMD

Obstetrics & Gynecology • Providence, RI

Gynecologic Oncology

Physician

Join to view full profile

Dr. Sakr is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Sakr's full profile

Already have an account?

Office
101 Dudley st
Providence, RI 02905
Phone+1 401-453-7540

Fax+1 401-453-7785

Education & Training

UPMC Medical EducationFellowship, Hematology and Medical Oncology, 1999 - 2002
Wayne State University School of MedicineResidency, Internal Medicine, 1996 - 1999
Lebanese University School of MedicineClass of 1995

Certifications & Licensure

MA State Medical License 2007 - 2026
RI State Medical License 2002 - 2026
PA State Medical License 2000 - 2002
MI State Medical License 1996 - 1999
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse Start of enrollment: 2007 Nov 01
Terminated
Phase 2
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer Start of enrollment: 2012 Apr 01
Terminated
Phase 2
Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Start of enrollment: 2014 Jan 15
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
Neoadjuvant weekly paclitaxel and carboplatin with trastuzumab and pertuzumab in HER2-positive breast cancer: a Brown University Oncology Research Group (BrUOG) study.
Mary L Lopresti, Jessica J Bian, Bachir J. Sakr, Rochelle Strenger, Robert D. Legare
Breast Cancer Research and Treatment. 2021-06-04
75 citations
Medical Marijuana Use in Oncology: A Review
Gianna Wilkie, Bachir J. Sakr, Tina Rizack
JAMA Oncology. 2016-05-01
7 citations
Advances in Medical Management of Early Stage and Advanced Breast Cancer: 2015
Sabrina M Witherby, Tina Rizack, Bachir J. Sakr, Robert D. Legare, William M. Sikov
Seminars in Radiation Oncology. 2016-01-01